Visit link:
PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors
Author Archives: Fredricko
Aligos Therapeutics Presents Clinical Data for its NASH Program and Nonclinical Data for its Chronic Hepatitis B Portfolio at AASLD’s The Liver…
Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022
Read more from the original source:
Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
hC Bioscience Announces Extension of Series A to $40 Million
Read the original post:
hC Bioscience Announces Extension of Series A to $40 Million
ExCellThera announces oral presentation of new data on UM171-expanded cell therapy at the ASH Annual Meeting
Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and CHK-336 Preclinical Efficacy…
Molecular Templates, Inc. to Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Orion Corporation: Acquisition of Own Shares 04.11.2022
Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single…
Orion Corporation completed share acquisitions
See the original post here:
Orion Corporation completed share acquisitions
VALNEVA – Declaration of shares and voting rights: October 31, 2022
Originally posted here:
VALNEVA - Declaration of shares and voting rights: October 31, 2022